Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
212.2 USD | +15.70% | +17.26% | +21.92% |
03:09pm | Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating | MT |
03:00pm | JPMorgan Adjusts Price Target on ResMed to $225 From $198 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.92% | 26.94B | |
+8.02% | 218B | |
+6.26% | 182B | |
+11.31% | 132B | |
+26.81% | 108B | |
+11.61% | 52.98B | |
-1.89% | 47.59B | |
-1.24% | 39.96B | |
+11.34% | 39.22B | |
-12.12% | 19.28B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Posts Flat Fiscal Q1 Adjusted EPS, Higher Revenue; Quarterly Dividend Maintained at $0.44 a Share